← Browse by Condition
Medical Condition
cholangiocarcinoma
Total Trials
12
Recruiting Now
12
Trial Phases
Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for cholangiocarcinoma sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — cholangiocarcinoma Clinical Trials
How many clinical trials are currently recruiting for cholangiocarcinoma?
ClinicalMetric currently tracks 12 actively recruiting clinical trials for cholangiocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cholangiocarcinoma?
cholangiocarcinoma research spans Phase 1 (1 trial), Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cholangiocarcinoma clinical trial?
Eligibility criteria for cholangiocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Phase 2 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05187312
Recruiting
Enrollment
1,000 pts
Location
Sweden
Sponsor
Region Stockholm
NCT03637569
Recruiting
Enrollment
1,000 pts
Location
South Korea
Sponsor
Samsung Medical Center
NCT07478523 Phase 2
Recruiting
Enrollment
120 pts
Location
France
Sponsor
University Hospital, Bordeaux
NCT07224750
Recruiting
Enrollment
1,000 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT07155525
Recruiting
Enrollment
194 pts
Location
Egypt
Sponsor
Minia University
NCT05714124
Recruiting
Enrollment
580 pts
Location
Italy
Sponsor
IRCCS San Raffaele
NCT04340986
Recruiting
Enrollment
1,250 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT04753996
Recruiting
Enrollment
300 pts
Location
United States
Sponsor
Mayo Clinic
NCT07760012
Recruiting
Enrollment
50 pts
Location
China
Sponsor
Peking University Third Hospit...
NCT06126406 Phase 1
Recruiting
Enrollment
60 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
NCT06342414
Recruiting
Enrollment
400 pts
Location
United States, Japan
Sponsor
City of Hope Medical Center
NCT05321992
Recruiting
Enrollment
480 pts
Location
Thailand
Sponsor
McMaster University
Related Conditions
hepatocellular carcinoma (4) pancreatic cancer (3) pancreas cancer (2) primary liver cancer (2) lung cancer (2) breast cancer (2) sclerosing cholangitis (1) gallbladder cancer (1) pancreatic adenocarcinoma (1) hepatocellular carcinoma hcc (1) pancreatic ductal adenocarcinoma pdac (1) esophageal squamous cell carcinoma escc (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology